XML 27 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheet Components (Tables)
6 Months Ended
Jul. 27, 2014
Notes to financial statements [Abstract]  
Inventories
 
July 27,
 
January 26,
 
2014
 
2014
Inventories:
(In thousands)
Raw materials
$
126,191

 
$
126,896

Work in-process
85,895

 
94,844

Finished goods
175,348

 
166,025

Total inventories
$
387,434

 
$
387,765

Accrued Liabilities
 
July 27,
 
January 26,
 
2014
 
2014
Accrued Liabilities and Other:
(In thousands)
Deferred revenue, short-term
$
265,704

 
$
265,616

Accrued customer programs (1)
131,973

 
157,840

Accrued payroll and related expenses
112,024

 
109,721

Accrued legal settlement (2)
30,600

 
30,600

Professional service fees
12,218

 
13,572

Customer advances
11,329

 
9,297

Office lease related liabilities
8,549

 
3,139

Warranty accrual (3)
8,202

 
7,571

Taxes payable, short-term
5,810

 
2,378

Coupon interest on Notes
2,542

 
2,500

Other
18,151

 
18,871

Total accrued liabilities and other
$
607,102

 
$
621,105

      
(1) Please refer to Note 1 of the Notes to the Consolidated Financial Statements in our Annual Report on Form 10-K for the fiscal year ended January 26, 2014, for discussion regarding the nature of accrued customer programs and their accounting treatment related to our revenue recognition policies and estimates. 
(2)  Please refer to Note 12 of these Notes to Condensed Consolidated Financial Statements for discussion regarding the 3dfx litigation. 
(3)  Please refer to Note 10 of these Notes to Condensed Consolidated Financial Statements for discussion regarding the warranty accrual.
Other Long-term Liabilities
 
July 27,
 
January 26,
 
2014
 
2014
Other Long-Term Liabilities:
(In thousands)
Deferred income tax liability
$
192,702

 
$
157,953

Income taxes payable, long-term
119,661

 
119,977

Deferred revenue, long-term (1)
40,063

 
172,199

Asset retirement obligation
7,386

 
11,056

Other long-term liabilities
14,301

 
13,940

Total other long-term liabilities
$
374,113

 
$
475,125



(1) Consists primarily of annual consideration received in advance of our performance obligation under our patent cross licensing agreement with Intel Corporation entered into in January 2011. The decrease in deferred revenue, long-term, is a result of revenue recognized during the six months ended July 27, 2014.